Latest Patents News

Page 17 of 104
Canadian Phosphate has secured a five-year exploration permit for its Wapiti Phosphate Project and commenced a 3,000m drilling campaign, while progressing the pending acquisition of the Diamond Mountain Project in Utah. A $5.2 million capital raise positions the company to accelerate its North American phosphate ambitions.
Maxwell Dee
Maxwell Dee
29 July 2026
Olympio Metals has completed Phase 2 drilling at its Bousquet Gold Project with 36 new significant gold intercepts, bringing the total to 138. The company also commenced Phase 3 drilling targeting extensions of a high-grade lode and secured an 80% interest in the Jacknife Silver Project in Idaho, USA.
Maxwell Dee
Maxwell Dee
28 July 2026
Argent BioPharma has eliminated US$5.5 million in secured debt through a global licensing agreement for its CannEpil® epilepsy therapy, while completing a key acquisition and advancing clinical trials in veterinary therapeutics.
Ada Torres
Ada Torres
28 July 2026
Reward Minerals (ASX:RWD) reported strong gold and copper assay results from its Mountain Pond Project in Newfoundland, with preparations underway for maiden drilling in the September quarter. The company also advanced its potash processing technology and ongoing discussions for the Beyondie Potash Plant in Western Australia.
Maxwell Dee
Maxwell Dee
27 July 2026
Proteomics International Laboratories has streamlined operations, secured a key US patent for its endometriosis test, and inked a three-year exclusive distribution deal with Healius for its Promarker diagnostics in Australia.
Ada Torres
Ada Torres
27 July 2026
Firebrick Pharma expanded its patent portfolio with grants in Canada and New Zealand while achieving 43% sales growth in FY26 despite steady operating expenses. The company is advancing Nasodine's commercial rollout across Southeast Asia and the US.
Ada Torres
Ada Torres
27 July 2026
Syntara secured positive FDA feedback for its Phase 2b amsulostat trial in myelofibrosis and raised $8 million to extend its cash runway to Q3 2027, while preliminary data showed promising brain inflammation reduction in a Parkinson’s-related disorder.
Ada Torres
Ada Torres
27 July 2026
BlinkLab has bolstered its war chest with a A$17.5 million placement, secured a foundational US patent valid through 2041, and made significant progress in its FDA autism diagnostic trial and European ADHD study.
Ada Torres
Ada Torres
27 July 2026
Nyrada has dosed the first patient in its Phase IIa trial of Xolatryp targeting heart attack recovery, while strengthening its cash reserves and receiving a US patent allowance for its lead drug.
Ada Torres
Ada Torres
27 July 2026
Patrys Limited is pushing forward with a proprietary injectable formulation of quetiapine targeting the lucrative delirium treatment market, leveraging a faster, lower-cost FDA 505(b)(2) regulatory pathway and strong patent protection.
Ada Torres
Ada Torres
27 July 2026
Orbital Corporation's 150HFE propulsion system has powered its inaugural flight on AATI's AiRanger UAV, triggering follow-on orders worth over US$750,000 and signalling growth in UAV propulsion sales and service revenue.
Maxwell Dee
Maxwell Dee
24 July 2026
Diablo Resources has acquired an 80% stake in the historic Horn Silver Project, complementing its nearby Star Range assets and advancing exploration with a maiden drill program approved.
Maxwell Dee
Maxwell Dee
24 July 2026

Browse the archive

Full archive